/HUGE.CN

HUGE.CN Stock - FSD Pharma Inc.

Q: What is the analyst price target for HUGE.CN?

Analyst price target information is not currently available for HUGE.CN.

Q: What is HUGE.CN's market cap?

Market capitalization information is not currently available for HUGE.CN.

Healthcare|Drug Manufacturers - Specialty & Generic|CNQ

$0.13-13.79%

$0.02 (-13.79%) • Aug 14

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.14

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for HUGE.CN

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2019

FY2020

FY2021

FY2022

FY2023

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.85

52W High$144.95

52W Low$0.13

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2023	FY2022	FY2021	FY2020	FY2019
Revenue	N/A	N/A	N/A	N/A	$196,819
Gross Profit	$-3,382,742	$-5,907,049	$-5,072,004	$-5,231,688	$-1,842,651
Gross Margin	N/A	N/A	N/A	N/A	-936.2%
Operating Income	$-25,484,066	$-27,429,611	$-33,743,660	$-30,691,088	$-28,072,294.395
Net Income	$-23,719,850	$-23,322,074	$-35,405,917	$-32,719,229	$-40,053,255.453
Net Margin	N/A	N/A	N/A	N/A	-20350.3%
EPS	$-0.60	$-0.60	$-1.01	$-2.72	$-5.68

Company Overview

FSD Pharma Inc., a biotechnology company, operates in the pharmaceutical research and development business. Its lead candidate is FSD201, a palmitoylethanolamide for the treatment of inflammatory diseases. The company is also involved in the research and development of Lucid-Psych, a molecular compound identified for the treatment of mental health disorders; and Lucid-MS, a molecular compound identified for the treatment of neurodegenerative disorders. FSD Pharma Inc. is headquartered in Toronto, Canada.

Visit Website

Earnings History & Surprises

HUGE.CN

Beat Rate

80%

Last 5 quarters

Avg Surprise

+35.9%

EPS vs Estimate

Beats / Misses

4/1

Last 12 quarters

Latest EPS

$-0.07

Q3 2024

EPS Surprise History

Q3 22

No data

Q1 23

No data

Q2 23

No data

Q3 23

No data

Q4 23

+84.8%

$-0.03vs$-0.19

Q1 24

+82.3%

$-0.03vs$-0.19

Q2 24

+29.7%

$-0.05vs$-0.07

Q3 24

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q3 2025	Aug 12, 2025	—	—	—	—
Q2 2025	May 12, 2025	—	—	—	—
Q1 2025	Mar 26, 2025	—	—	—	—
Q4 2024	Nov 12, 2024	—	—	—	—
Q3 2024	Aug 14, 2024	—	$-0.07	—	—
Q2 2024	May 14, 2024	$-0.07	$-0.05	+29.7%	✓ BEAT
Q1 2024	Mar 28, 2024	$-0.19	$-0.03	+82.3%	✓ BEAT
Q4 2023	Nov 14, 2023	$-0.19	$-0.03	+84.8%	✓ BEAT
Q3 2023	Jul 20, 2023	—	$-0.21	—	—
Q2 2023	May 12, 2023	—	$-0.28	—	—
Q1 2023	Mar 29, 2023	—	$-0.15	—	—
Q3 2022	Sep 30, 2022	—	$-0.19	—	—
Q2 2022	Jun 30, 2022	—	$-0.12	—	—
Q1 2022	Mar 31, 2022	—	$-0.14	—	—
Q4 2021	Dec 31, 2021	—	$-0.16	—	—
Q4 2021	Nov 12, 2021	—	$-0.16	—	—
Q3 2021	Aug 12, 2021	—	$-0.37	—	—
Q2 2021	May 8, 2021	—	$-0.37	—	—
Q1 2021	Mar 17, 2021	$-1.40	$-0.34	+75.7%	✓ BEAT
Q4 2020	Nov 12, 2020	$-0.71	$-1.37	-93.0%	✗ MISS

Frequently Asked Questions about HUGE.CN

What is HUGE.CN's current stock price?

FSD Pharma Inc. (HUGE.CN) is currently trading at $0.13 per share. The stock has moved -13.79% today.

What is the analyst price target for HUGE.CN?

No analyst price targets are currently available for this stock.

What sector is FSD Pharma Inc. in?

FSD Pharma Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the CNQ exchange.

What is HUGE.CN's market cap?

FSD Pharma Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does HUGE.CN pay dividends?

No, FSD Pharma Inc. does not currently pay a dividend to shareholders.